PATENT CLAIM ANALYSIS

Application Number: 15870306
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of an ANGPTL3 mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions for reducing plasma lipids, plasma glucose and atherosclerotic plaques in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate any one or more of cardiovascular disease or metabolic disease, or a symptom thereof.

Claim (Index 1):
A method for treating an animal with metabolic or cardiovascular disease comprising\n a. identifying said animal with metabolic or cardiovascular disease, b. administering to said animal a therapeutically effective amount of a compound comprising a modified oligonucleotide having at least 20 linked nucleosides and having a nucleobase sequence comprising at least 8 contiguous nucleobases of a nucleobase sequence selected from any of SEQ ID NO: 34-182 wherein said animal with metabolic or cardiovascular disease is treated.

Metadata:
- Claim Count in Document: 61.0
- Percentile: 86.0
- Lexical Diversity: 1.86047
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14149715', '13520997', '14959714', '14701999', '14552436']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8071661313248482
- 35 USC 102 Novelty (BERT): 0.5634742343799448
- Combined Prediction Score: 0.7827969416303578
- Mean Citation Score: 453.858652
- Max Citation Score: 537.817
- Similarity Product: 320.7876018897295

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test